Your browser doesn't support javascript.
loading
A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
Kalgutkar, Amit S; Driscoll, James; Zhao, Sabrina X; Walker, Gregory S; Shepard, Richard M; Soglia, John R; Atherton, James; Yu, Linning; Mutlib, Abdul E; Munchhof, Michael J; Reiter, Lawrence A; Jones, Christopher S; Doty, Johnathan L; Trevena, Kristen A; Shaffer, Christopher L; Ripp, Sharon L.
Affiliation
  • Kalgutkar AS; Pharmacokinetics, Dynamics and Metabolism Department, Pfizer Global Research and Development, Groton, Connecticut 06340, USA. amit.kalgutkar@pfizer.com
Chem Res Toxicol ; 20(12): 1954-65, 2007 Dec.
Article in En | MEDLINE | ID: mdl-17935300
Search on Google
Database: MEDLINE Main subject: Pyridines / Thiazoles / Receptors, Thrombopoietin Type of study: Risk_factors_studies Limits: Animals / Humans / Male Language: En Year: 2007 Type: Article
Search on Google
Database: MEDLINE Main subject: Pyridines / Thiazoles / Receptors, Thrombopoietin Type of study: Risk_factors_studies Limits: Animals / Humans / Male Language: En Year: 2007 Type: Article